Dr. Edward Fry, new President of the American College of Cardiology, discusses the results of the POISE-3 trial, which investigated the efficacy and safety of tranexamic acid in patients undergoing noncardiac surgery.
Reduction of Bleeding with Tranexamic Acid After Noncardiac Surgery
Facebook Comments